Russell Investments Group’s Medicines Co MDCO Stock Holding History

Russell Investments Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,245	Closed	-$2.57M	–	3237
2019 Q4	$2.57M	Buy	30,245 +3,939	+15%	+$263K	﹤0.01%	1585
2019 Q3	$1.31M	Buy	+26,306	New	+$1.05M	﹤0.01%	1876
2019 Q2	–	Sell	-5,589	Closed	-$156K	–	3027
2019 Q1	$156K	Sell	5,589 -2,351	-30%	-$55.4K	﹤0.01%	2660
2018 Q4	$152K	Sell	7,940 -4,411	-36%	-$103K	﹤0.01%	2655
2018 Q3	$369K	Hold	12,351	–	–	﹤0.01%	2518
2018 Q2	$453K	Sell	12,351 -5	-0%	-$162	﹤0.01%	2424
2018 Q1	$407K	Buy	12,356 +426	+4%	+$13.3K	﹤0.01%	2525
2017 Q4	$330K	Hold	11,930	–	–	﹤0.01%	2559
2017 Q3	$442K	Buy	11,930 +290	+2%	+$10.7K	﹤0.01%	2485
2017 Q2	$442K	Sell	11,640 -11,475	-50%	-$511K	﹤0.01%	2462
2017 Q1	$1.13M	Buy	23,115 +13,237	+134%	+$604K	﹤0.01%	2034
2016 Q4	$336K	Buy	+9,878	New	+$350K	﹤0.01%	2584

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Russell Investments Group's MDCO Position: Q1 2020 in Review

Russell Investments Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 30,245 shares — an estimated $2.57M sold.

Russell Investments Group first reported a position in MDCO in Q4 2016 and held it in 12 quarters. The position peaked at $2.57M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Russell Investments Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Russell Investments Group sold 30,245 Medicines Co shares in Q1 2020, an estimated $2.57M.
Russell Investments Group first reported a position in Medicines Co in Q4 2016 and held it in 12 quarters.
Russell Investments Group's Medicines Co position peaked at $2.57M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Russell Investments Group's 13F filing for Q1 2020, filed 6 May 2020.